Esther Krofah, Executive Vice President at Milken Institute Health shared a post on LinkedIn:
“It was a privilege to convene Cancer 2035: A Roadmap for the Future, as a partnership with the Milken Institute and the Richard Nixon Foundation, to mark the 55th anniversary of the National Cancer Act, a landmark legislation signed by President Nixon that reshaped the nation’s approach to cancer and laid the foundation for decades of scientific and clinical advancement.
We brought together leading oncologists, researchers, policymakers, and industry experts to examine how today’s scientific and technological capabilities can drive the next era of biomedical progress.
During the event, Dr. Mehmet Oz and Dr. Tony Letai underscored the urgency of bridging the gap between research and real-world care. Whether it was Dr. Oz’s vision of using AI to act as a personal healthcare navigator or Dr. Letai’s call for a more coordinated clinical trial ecosystem, the sentiment was the same: the “siloed” way of doing things must be a thing of the past.
From elected officials like Senator Shelley Moore Capito and Congresswoman Diana DeGette to innovators like Lee Hood, Noubar Afeyan and George Yancopoulos to former NIH Directors Monica Bertagnolli, Francis Collins, and Elias Zerhouni, there was broad agreement that a future where cancer is predictable, manageable, and curable is within reach.
Thanks to a brilliant panel focused on Designing the Clinical Trials Infrastructure of the Future with Richard Pazdur, Ed Kim, Marjorie Green, and Padmanee Sharma who highlighted how we must make the U.S. an attractive destination for conducting trials and ensuring we have site networks across the country for all patients to have the choice to participate in research.
Finally, I’d like to extend a huge congratulations to Marlene Malek, Vice Chair and Co-founder of Friends of Cancer Research who received the Legacy of Hope Award. While technology and policy are the engines of change, it is tireless advocates like Marlene who are the fuel that keeps us moving toward a cancer-free future.
Special thanks to Andrew von Eschenbach M.D and the team at Richard Nixon Foundation for their partnership in putting on this event.
Watch the event discussion here.”
Other articles featuring Esther Krofah on OncoDaily.
